Mediclinic FY core profit falls on Swiss regulatory changes

JOHANNESBURG, May 23 (Reuters) - Mediclinic International Plc MDCM.L, MEIJ.J reported a 4% fall in full-year core profit on Thursday, in line with market expectations, reflecting the impact of regulatory changes on its Swiss business.

Adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) for the year ended March 31 fell to 493 million pounds ($623.20 million) from 515 million, in line with estimates in a Refinitiv poll.

Mediclinic, which also has operations in southern Africa and the Middle East, has faced stricter regulations in Switzerland that have hobbled growth and put pressure on margins. These include tariff reductions for outpatients and a less favourable insurance mix.

($1 = 0.7911 pounds)

(Reporting by Nqobile Dludla; editing by Jason Neely)

((; +27117753126; Reuters Messaging:

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.